ARS Investment Partners’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

ARS Investment Partners’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-78,269	Closed	-$134K	–	168
2022 Q4	$134K	Sell	78,269 -2,891	-4%	-$6.38K	0.02%	134
2022 Q3	$169K	Sell	81,160 -5,716	-7%	-$11.4K	0.02%	156
2022 Q2	$223K	Buy	86,876 +9,849	+13%	+$31.5K	0.03%	131
2022 Q1	$337K	Buy	77,027 +15,164	+25%	+$63.4K	0.03%	120
2021 Q4	$282K	Buy	61,863 +19,799	+47%	+$107K	0.03%	136
2021 Q3	$253K	Buy	42,064 +9,623	+30%	+$69.3K	0.03%	137
2021 Q2	$336K	Sell	32,441 -22,081	-40%	-$211K	0.03%	116
2021 Q1	$417K	Buy	+54,522	New	+$361K	0.05%	103

Other funds holding NMRD

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

ARS Investment Partners's NMRD Position: Q1 2023 in Review

ARS Investment Partners sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2023, closing a stake of 78,269 shares — an estimated $134K sold.

ARS Investment Partners first reported a position in NMRD in Q1 2021 and held it in 8 quarters. The position peaked at $417K in Q1 2021. 16 funds tracked by Wall St. Rank hold NMRD as of Q1 2023.

ARS Investment Partners reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
ARS Investment Partners sold 78,269 Nemaura Medical, Inc. Common Stock shares in Q1 2023, an estimated $134K.
ARS Investment Partners first reported a position in Nemaura Medical, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
ARS Investment Partners's Nemaura Medical, Inc. Common Stock position peaked at $417K in Q1 2021.
16 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2023.

Based on ARS Investment Partners's 13F filing for Q1 2023, filed 5 Apr 2023.